We are live on ! Find out more
PRLD icon

Prelude Therapeutics
PRLD

51 hedge funds and large institutions have $2.47B invested in Prelude Therapeutics in 2020 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

149% more capital invested

Capital invested by funds: $994M → $2.47B (+$1.48B)

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

67% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 18

31% more funds holding

Funds holding: 39 → 51 (+12)

0.82% more ownership

Funds ownership: 78.48% → 79.29% (+0.82%)

0% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 7

Holders
51
Holders Change
+12
Holders Change %
+30.77%
% of All Funds
0.9%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
30
Increased
7
Reduced
7
Closed
18
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$53.8M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$30.6M
3
BlackRock
BlackRock
New York
+$28.6M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$9.53M
5
State Street
State Street
Massachusetts
+$7.08M

Top Sellers

Rank Fund Capital Flow
1
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
-$11.6M
2
UBS AM
UBS AM
Illinois
-$10.5M
3
SCM
Suvretta Capital Management
New York
-$5.67M
4
WP
Woodline Partners
California
-$5.4M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$4.69M
Name Holding Trade Value Shares
Change 		Change in
Stake
California State Teachers Retirement System (CalSTRS)
26
California State Teachers Retirement System (CalSTRS)
California
$994K +$691K +13,888 New
RhumbLine Advisers
27
RhumbLine Advisers
Massachusetts
$683K +$475K +9,546 New
AllianceBernstein
28
AllianceBernstein
Tennessee
$615K +$428K +8,600 New
AIP
29
ARS Investment Partners
New York
$529K +$368K +7,400 New
New York State Common Retirement Fund
30
New York State Common Retirement Fund
New York
$515K +$358K +7,200 New
Deutsche Bank
31
Deutsche Bank
Germany
$483K +$336K +6,750 New
Manulife (Manufacturers Life Insurance)
32
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$378K +$263K +5,289 New
Wells Fargo
33
Wells Fargo
California
$344K +$239K +4,806 New
PCS
34
Personal CFO Solutions
New Jersey
$322K +$224K +4,500 New
MIM
35
MetLife Investment Management
New Jersey
$295K +$205K +4,119 New
VOYA Investment Management
36
VOYA Investment Management
Georgia
$262K +$182K +3,665 New
OWP
37
Old Well Partners
North Carolina
$247K +$172K +3,450 New
AC
38
Athanor Capital
New York
$241K +$168K +3,374 New
MLICM
39
Metropolitan Life Insurance Company (MetLife)
New York
$206K +$143K +2,879 New
Royal Bank of Canada
40
Royal Bank of Canada
Ontario, Canada
$203K +$141K +2,831 New
UBS Group
41
UBS Group
Switzerland
$185K +$57.6K +1,158 +81%
SO
42
STRS Ohio
Ohio
$157K +$109K +2,200 New
Citigroup
43
Citigroup
New York
$124K +$86.1K +1,731 New
Bank of Montreal
44
Bank of Montreal
Ontario, Canada
$98K +$71.3K +1,434 New
Legal & General Group
45
Legal & General Group
United Kingdom
$72K -$3.01M -60,485 -98%
AIP
46
Ameritas Investment Partners
Nebraska
$55K +$38.2K +769 New
Bank of America
47
Bank of America
North Carolina
$35K +$23.9K +480 +4,800%
JCM
48
Jacobi Capital Management
Pennsylvania
$18K -$12.4K -250 -50%
TRCT
49
Tower Research Capital (TRC)
New York
$15K +$10.2K +205 New
US Bancorp
50
US Bancorp
Minnesota
$1K +$895 +18 New
1
2
3

PRLD Hedge Fund Activity: Q4 2020 in Review

51 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Prelude Therapeutics (PRLD) for Q4 2020, worth a combined $2.47B — up 149% from $994M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new PRLD positions and 18 closed out — a net gain of 12 holders — while 7 added to existing stakes and 7 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $53.8M. The largest seller was Massachusetts Financial Services, cutting an estimated $11.6M.

  • 51 institutional investors held Prelude Therapeutics (PRLD) as of Q4 2020, up from 39 in Q3 2020.
  • Funds reported $2.47B of Prelude Therapeutics stock for Q4 2020, up 149% quarter-over-quarter.
  • 30 funds opened new Prelude Therapeutics positions in Q4 2020 and 18 closed out, a net change of +12 holders.
  • The largest Prelude Therapeutics buyer in Q4 2020 was Fidelity Investments, an estimated $53.8M added.
  • The largest Prelude Therapeutics seller in Q4 2020 was Massachusetts Financial Services, an estimated $11.6M sold.

Based on aggregated 13F filings for Q4 2020.